Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. Academic Article uri icon

Overview

authors

  • Abu-Raddad, Laith Jamal
  • Chemaitelly, Hiam Souheil
  • Yassine, Hadi M
  • Benslimane, Fatiha M
  • Al Khatib, Hebah A
  • Tang, Patrick
  • Malek, Joel A
  • Coyle, Peter
  • Ayoub, Houssein H
  • Al Kanaani, Zaina
  • Al Kuwari, Einas
  • Jeremijenko, Andrew
  • Kaleeckal, Anvar Hassan
  • Latif, Ali Nizar
  • Shaik, Riyazuddin Mohammad
  • Abdul Rahim, Hanan F
  • Nasrallah, Gheyath K
  • Al Kuwari, Mohamed Ghaith
  • Al Romaihi, Hamad Eid
  • Al-Thani, Mohamed H
  • Al Khal, Abdullatif
  • Butt, Adeel A
  • Bertollini, Roberto

publication date

  • October 11, 2021

Research

keywords

  • COVID-19
  • COVID-19 Vaccines

Identity

PubMed Central ID

  • PMC8194836

Scopus Document Identifier

  • 85109957260

Digital Object Identifier (DOI)

  • 10.1056/NEJMc2104974

PubMed ID

  • 34050372

Additional Document Info

volume

  • 28

issue

  • 7